Cutler Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,500
Closed -$1K 5430
2022
Q2
$1K Buy
6,500
+3,900
+150% +$52.1K ﹤0.01% 4708
2022
Q1
$2K Buy
+2,600
New +$35.6K ﹤0.01% 4755
2019
Q4
Sell
-28,900
Closed -$36K 4522
2019
Q3
$36K Buy
28,900
+17,900
+163% +$382K ﹤0.01% 1774
2019
Q2
$1K Buy
+11,000
New +$214K ﹤0.01% 3967
2018
Q2
Sell
-2,800
Closed -$1K 4775
2018
Q1
$1K Buy
+2,800
New +$49.4K ﹤0.01% 4139
2017
Q4
Sell
-13,900
Closed -$24K 5793
2017
Q3
$24K Buy
+13,900
New +$314K ﹤0.01% 2967

Other funds holding SBRA

Cutler Group's SBRA Position: Q3 2021 in Review

Cutler Group sold out of Sabra Healthcare REIT (SBRA) in Q3 2021, closing a stake of 100 shares — an estimated $1.69K sold.

Cutler Group first reported a position in SBRA in Q3 2016 and held it in 14 quarters. The position peaked at $291K in Q3 2017. 326 funds tracked by Wall St. Rank hold SBRA as of Q3 2021.

  • Cutler Group reported no remaining Sabra Healthcare REIT position as of Q3 2021 after selling out during the quarter.
  • Cutler Group sold 100 Sabra Healthcare REIT shares in Q3 2021, an estimated $1.69K.
  • Cutler Group first reported a position in Sabra Healthcare REIT in Q3 2016 and held it in 14 quarters.
  • Cutler Group's Sabra Healthcare REIT position peaked at $291K in Q3 2017.
  • 326 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2021.

Based on Cutler Group's 13F filing for Q3 2021, filed 26 Oct 2021.